# Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity

> **NCT07504172** · — · NOT_YET_RECRUITING · sponsor: **Radboud University Medical Center** · enrollment: 1700 (estimated)

## Conditions studied

- Overweight , Obesity
- Obesity (Disorder)

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07504172
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 1700 (ESTIMATED)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07504172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07504172, "Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07504172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*